Clinical

Dataset Information

0

Cancer therapy with vaccination using HLA-A02 restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study patients with unresectable colorectal cancer


ABSTRACT: Interventions: Vaccination Primary outcome(s): Safety Study Design: Single arm Non-randomized

DISEASE(S): Unresectable Colorectal Cancer

PROVIDER: 2616207 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2616208 | ecrin-mdr-crc
| 2616206 | ecrin-mdr-crc
| 2616285 | ecrin-mdr-crc
| 2616205 | ecrin-mdr-crc
| S-EPMC3442373 | biostudies-literature
| S-EPMC2970665 | biostudies-literature
| S-EPMC4517055 | biostudies-literature
| S-EPMC8488270 | biostudies-literature
| S-EPMC7922143 | biostudies-literature
| S-EPMC2841949 | biostudies-literature